VCYT

SEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 1

Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 326,271

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale.

SEC source: 0001584145-25-000010 · wk-form4_1764895427.xml · nonDerivative · entry 1

Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,420

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale.

SEC source: 0001020741-25-000006 · wk-form4_1764192433.xml · nonDerivative · entry 1

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,362

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.005 to $50.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001991536-25-000006 · wk-form4_1764192442.xml · nonDerivative · entry 1

Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,291

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025.

SEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 3

Holstein Jens · CIK 0001819880 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,199

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.075 to $43.37. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 2

Holstein Jens · CIK 0001819880 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,659

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $41.89 to $42.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001819880-25-000005 · wk-form4_1763759939.xml · nonDerivative · entry 1

Holstein Jens · CIK 0001819880 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,708

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.86 to $41.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001584145-25-000008 · wk-form4_1762982744.xml · nonDerivative · entry 2

Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,745

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.2866 to $42.4436. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001584145-25-000008 · wk-form4_1762982744.xml · nonDerivative · entry 1

Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,847

F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.06 to $40.958. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · derivative · entry 12

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F8 · derivative.exercise_date: The option is fully vested.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · derivative · entry 11

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F8 · derivative.exercise_date: The option is fully vested.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · derivative · entry 10

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2026-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F8 · derivative.exercise_date: The option is fully vested.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 9

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,468

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F7 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.35 to $46.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 8

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,125

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F6 · price: Represents weighted average sales price. Sale prices for the transactions range from $45.34 to $44.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 7

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,421

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $44.335 to $45.335. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 6

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,293

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.29 to $44.29. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 5

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,130

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.285 to $43.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 4

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,256

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $41.10 to $41.97. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 3

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 2

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

SEC source: 0001020741-25-000004 · wk-form4_1762549821.xml · nonDerivative · entry 1

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.

SEC source: 0001914620-25-000008 · wk-form4_1762549830.xml · nonDerivative · entry 1

McGuire Annie · CIK 0001914620 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,973

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.

SEC source: 0001231845-25-000005 · wk-form4_1762549815.xml · nonDerivative · entry 1

EASTHAM KARIN · CIK 0001231845 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,554

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.00 to $40.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001823563-25-000005 · wk-form4_1762549809.xml · nonDerivative · entry 1

Chambers Rebecca · CIK 0001823563 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,158

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.

SEC source: 0001584145-25-000006 · wk-form4_1761856769.xml · nonDerivative · entry 1

Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,665

F1 · kind: Restricted stock units awarded on October 28, 2025 vest in full on the first anniversary of the grant date subject to continuing employment of the Reporting Person.

SEC source: 0001649245-25-000005 · wk-form4_1759868872.xml · nonDerivative · entry 1

Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,441

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.82 to $36.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001914620-25-000006 · wk-form4_1759522563.xml · nonDerivative · entry 1

McGuire Annie · CIK 0001914620 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,439

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001252004-25-000005 · wk-form4_1759522571.xml · derivative · entry 3

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.

SEC source: 0001252004-25-000005 · wk-form4_1759522571.xml · nonDerivative · entry 2

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,446

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001252004-25-000005 · wk-form4_1759522571.xml · nonDerivative · entry 1

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.

SEC source: 0001991536-25-000004 · wk-form4_1759522582.xml · nonDerivative · entry 1

Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,099

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025.

SEC source: 0001914620-25-000004 · wk-form4_1758658718.xml · nonDerivative · entry 1

McGuire Annie · CIK 0001914620 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,599

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $33.50 to $34.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-25-000124 · wk-form4_1757363611.xml · nonDerivative · entry 1

Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,185

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.22 to $30.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-25-000120 · wk-form4_1757020678.xml · nonDerivative · entry 1

McGuire Annie · CIK 0001914620 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,882

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

F2 · balance_after: Includes 386 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

SEC source: 0001384101-25-000122 · wk-form4_1757022311.xml · nonDerivative · entry 1

Chambers Rebecca · CIK 0001823563 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,158

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

SEC source: 0001384101-25-000118 · wk-form4_1757020563.xml · nonDerivative · entry 1

Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,852

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

F2 · balance_after: Includes 529 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

SEC source: 0001384101-25-000116 · wk-form4_1757020419.xml · nonDerivative · entry 1

Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,790

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

SEC source: 0001384101-25-000114 · wk-form4_1757020279.xml · nonDerivative · entry 1

Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,638

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

SEC source: 0001384101-25-000112 · wk-form4_1757019956.xml · nonDerivative · entry 1

Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,779

F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

F2 · balance_after: Includes 512 shares of common stock purchased on July 30, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

SEC source: 0001384101-25-000098 · wk-form4_1750709420.xml · nonDerivative · entry 1

Holstein Jens · CIK 0001819880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,199

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000097 · wk-form4_1750709409.xml · nonDerivative · entry 1

JONES EVAN/ FA · CIK 0001020741 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,664

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000093 · wk-form4_1750709365.xml · nonDerivative · entry 1

Miller Thomas F. · CIK 0002034921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,828

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000095 · wk-form4_1750709387.xml · nonDerivative · entry 1

Barr Eliav · CIK 0001940521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,189

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000096 · wk-form4_1750709399.xml · nonDerivative · entry 1

EPSTEIN ROBERT S · CIK 0001252004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,919

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000099 · wk-form4_1750709431.xml · nonDerivative · entry 1

EASTHAM KARIN · CIK 0001231845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,228

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000094 · wk-form4_1750709375.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,310

F1 · kind: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000092 · wk-form4_1750709354.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,828

F1 · shares: Restricted stock units awarded on June 18, 2025 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.

SEC source: 0001384101-25-000080 · wk-form4_1750191666.xml · nonDerivative · entry 1

EASTHAM KARIN · CIK 0001231845 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,907

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.39 to $26.92. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-25-000079 · wk-form4_1750191655.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,989

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 11, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.39 to $26.92. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

SEC source: 0001384101-25-000074 · wk-form4_1749241169.xml · nonDerivative · entry 1

Leite John · CIK 0001991536 · Chief Commercial Officer-CLIA

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,540

F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 6, 2024.

F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $26.82 to $27.36. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.